| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-09 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.04 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.006 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.03 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |